53334 Federal Register / Vol. 62, No. 198 / Tuesday, October 14, 1997 / Notices

Place: NIH, Rockledge 2, Room 4202,

Telephone Conference.

Contact Person: Dr. Calbert Laing,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4202, Bethesda,

Maryland 20892, (301) 435–1221.

Name of SEP: Biological and Physiological

Sciences.

Date: November 17–18, 1997.

Time: 8:30 a.m.

Place: George Washington University Inn,

Washington, DC.

Contact Person: Dr. Richard Marcus,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5194, Bethesda,

Maryland 20892, (301) 435–1256.

Name of SEP: Biological and Physiological

Sciences.

Date: November 19, 1997.

Time: 10:15 a.m.

Place: NIH, Rockledge 2, Room 5200,

Telephone Conference.

Contact Person: Dr. Bob Weller, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5200, Bethesda, Maryland 20892, (301)

435–1259.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Clinical Sciences.

Date: October 31, 1997.

Time: 9:00 a.m.

Place: Holiday Inn-Georgetown,

Washington, DC.

Contact Person: Dr. Nancy Shinowara,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5216, Bethesda,

Maryland 20892, (301) 435–1173.

Name of SEP: Biological and Physiological

Sciences.

Date: November 18–19, 1997.

Time: 8:30 a.m.

Place: Wyndham Bristol Hotel,

Washington, DC.

Contact Person: Dr. Camilla Day, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 6152, Bethesda, Maryland 20892, (301)

435–1037.

Name of SEP: Microbiological and

Immunological Sciences.

Date: November 19–20, 1997.

Time: 8:30 a.m.

Place: Ramada Inn, Rockville, Maryland.

Contact Person: Dr. Timothy Henry,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4180, Bethesda,

Maryland 20892, (301) 435–1147.

Name of SEP: Behavioral and

Neurosciences.

Date: November 21, 1997.

Time: 8:30 a.m.

Place: Bethesda Marriott, Bethesda,

Maryland.

Contact Person: Dr. Luigi Giacometti,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5170, Bethesda,

Maryland 20892, (301) 435–1236.

The meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: October 6, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27092 Filed 10–10–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meetings:

Name of SEP: Transfusion-Associated

Immunomodulation (TRIM) Telephone

Conference Call.

Date: November 5, 1997.

Time: 1:30 p.m.

Place: Two Rockledge Center, Room 7214,

6701 Rockledge Drive, Bethesda, Maryland

20892.

Contact Person: Louise Corman, Ph.D.,

Two Rockledge Center, Room 7180, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0270.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of SEP: Lipoprotein Metabolism in

Atherosclerosis.

Date: December 8–9, 1997.

Time: 7:30 p.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, Maryland

20815.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

sections 552b(c)(4) and 552b(c)(6), title 5

U.S.C. Applications and/or contract

proposals and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the applications and/or

proposals, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: October 6, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27095 Filed 10–10–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute of

Mental Health Special Emphasis Panel:

Agenda Purpose: To review and evaluate

grant applications.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: October 15, 1997.

Time: 11 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gavin T. Wilkom,

Parklawn Building, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857,

Telephone: 301, 443–4868.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: October 30, 1997.

Time: 1 p.m.

Place: Parklawn Building, Room 9C–18,

5600 Fishers Lane, Rockville, MD 20857.

Contact Person: Gavin T. Wilkom,

Parklawn Building, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857,

Telephone: 301, 443–4868.

The meetings will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than

fifteen days prior to the meetings due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

(Catalog of Federal Domestic Assistance

Program Numbers 93.242, 93.281, 93.282)

Dated: October 6, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–27094 Filed 10–10–97; 8:45 am]

BILLING CODE 4140–01–M